Entries by Maren Kühr

LowCross-Buffer

Antibody and sample diluent for minimizing nonspecific binding, cross-reactivities and matrix effects in immunoassays.

The SIDUS® technology platform

Originates from the in-depth experience and complete protocol system concerning the manufacture of viral vectors for vaccines or gene therapy.

TxCell gains Treg rights

French immunotherapy company TxCell has teamed up with Inserm Transfert, the tech transfer subsidiary of the French National Institute of Health and Medical Research Inserm, to develop immuno-suppressive regulatory T cells.

A fresh take on biotech?

For the second time, biotech communication start-up Labiotech hosted its event LBRefresh, this year in Paris, France. Participants enjoyed panel discussions, a start-up battle and intimate fireside chats…